Sage epilepsy study

Seven things to know about Sage Therapeutics' big epilepsy ...

★ ★ ★ ★ ☆

8/24/2017 · A new drug from Sage aims to treat patients with epilepsy so severe that they must be put into a coma to stop their seizures. Key data are expected soon.

Seven things to know about Sage Therapeutics' big epilepsy ...

Postpartum Depression (PPD) Research Studies & Clinical ...

★ ★ ★ ★ ☆

Sage is committed to developing novel medicines to treat life-altering CNS disorders. We are exploring new ways to think about and treat central nervous system (CNS) disorders. Our trials evaluate the safety and efficacy of our novel drug candidates in the disorders we study with the hope of potentially addressing gaps in available treatment ...

Postpartum Depression (PPD) Research Studies & Clinical ...

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy ...

★ ★ ★ ☆ ☆

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus (SRSE) ... For this study, SRSE is defined by the following criteria and in accordance with those used at major epilepsy treatment centers:

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy ...

Sage-547 – MGH Epilepsy Service

★ ★ ☆ ☆ ☆

The MGH Epilepsy Service in conjunction with the MGH Neurologicical Critical Care Unit is conducting a trial entitled “An Open-label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of SAGE-547 Injection as Adjunctive Therapy in the Treatment of Adults With Super-Refractory Status Epilepticus”.

Sage-547 – MGH Epilepsy Service

Sage's epilepsy drug fails to do better than ... - STAT

★ ★ ★ ★ ☆

9/12/2017 · Sage Therapeutics’ closely watched drug, brexanolone, did not do much better than a placebo in helping patients with a severe type of epilepsy, data from a phase 3 clinical trial show. Sage ...

Sage's epilepsy drug fails to do better than ... - STAT

Sage’s Drug For Rare Epilepsy Shows Promise in Small Study

★ ★ ☆ ☆ ☆

Sage (NASDAQ: SAGE) reports that SAGE-547, its lead drug, met all primary and secondary goals in a small, 12-patient clinical trial for super-refractory status epilepticus (SRSE), a rare, life ...

Sage’s Drug For Rare Epilepsy Shows Promise in Small Study

Sage stock sinks after epilepsy drug fails to beat placebo ...

★ ★ ★ ★ ☆

9/12/2017 · Shares in Sage Therapeutics, Inc. plunged by more than 20% Tuesday after the Cambridge biotech announced a Phase 3 study showed its lead candidate brexanolone was no better than placebo in treating patients with a severe type of epilepsy. Sage tested brexanolone in …

Sage stock sinks after epilepsy drug fails to beat placebo ...

A Study With SAGE-547 for Super-Refractory Status ...

★ ★ ★ ☆ ☆

6/23/2015 · A Study With SAGE-547 for Super-Refractory Status Epilepticus. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.

A Study With SAGE-547 for Super-Refractory Status ...

Parental cognitive appraisals and coping behaviours ...

★ ★ ☆ ☆ ☆

Management of childhood epilepsy places significant demands and increased stress on the family unit. How parents adjust to this illness-related stress is believed to be shaped by their cognitive appraisals of the situation and the coping behaviours that are employed (Wallander & Varni, 1992). We investigated the cognitive and behavioural strategies that regulated psychological symptomatology ...

Parental cognitive appraisals and coping behaviours ...

Medications for Early Life Epilepsy: Evidence Versus ...

★ ★ ★ ☆ ☆

Design, Setting, and Participants: The Early Life Epilepsy Study—a prospective, multicenter, observational cohort study conducted from March 1, 2012, to April 30, 2015, in 17 US medical centers—enrolled infants with nonsyndromic epilepsy and a first …

Medications for Early Life Epilepsy: Evidence Versus ...

Sage: Uses, Side Effects, Interactions, Dosage, and Warning

★ ★ ☆ ☆ ☆

Overview Information Sage is an herb. The leaf is used to make medicine. Sage is used for digestive problems, including loss of appetite, gas (), stomach pain (), diarrhea, bloating, and heartburn ...

Sage: Uses, Side Effects, Interactions, Dosage, and Warning

SAGE Therapeutics - Clinical-Stage Biopharmaceutical ...

★ ★ ★ ★ ☆

Learn more about Sage Therapeutics, a clinical-stage biopharmaceutical company committed to the treatment of central nervous system (CNS) disorders.

SAGE Therapeutics - Clinical-Stage Biopharmaceutical ...

Find a Clinical Trial | Epilepsy Foundation

★ ★ ☆ ☆ ☆

The Epilepsy Foundation’s Clinical Trials Portal connects participants to current trials and observational studies to help accelerate development and testing of new treatments. In this video, the Epilepsy Foundation’s Chief Scientific Officer Dr. Jacqueline French introduces one of her patients, Sally.

Find a Clinical Trial | Epilepsy Foundation

Epilepsy Currents | SAGE Publications Inc

★ ★ ★ ★ ★

Epilepsy Currents is an open access, bi-monthly current-awareness journal providing reviews, commentaries and abstracts from the world’s literature on the research and treatment of epilepsy.Epilepsy Currents surveys and comments on all important research and developments in a format that is easy to read and reference. Each issue is divided into two main sections: Basic Science …

Epilepsy Currents | SAGE Publications Inc

Sage’s epilepsy drug fails to do better than placebo in ...

★ ★ ★ ☆ ☆

Sage Therapeutics’ closely watched drug, brexanolone, did not do much better than a placebo in helping patients with a severe type of epilepsy, data from a phase 3 clinical trial show. Sage, which is based in Cambridge, Mass. expected brexanolone to lead to its first-ever drug approval.

Sage’s epilepsy drug fails to do better than placebo in ...

Adam Feuerstein on Twitter: "Meet the investor shorting ...

★ ★ ★ ★ ☆

8/28/2017 · Adam Feuerstein Verified account @adamfeuerstein Senior Writer at @statnews.I am the Night King of biotech. Data Are. Dogs rule. Said one analyst: …

Adam Feuerstein on Twitter:

Zynerba shares plunge as cannabis-based epilepsy gel fails ...

★ ★ ★ ★ ★

8/7/2017 · Zynerba Pharmaceuticals Inc's stock lost more than half its value on Monday after the U.S. drug developer said its synthetic cannabis-based gel for epilepsy failed a mid-stage study.

Zynerba shares plunge as cannabis-based epilepsy gel fails ...

Neurology in the Bay Area, CA | SAGE Veterinary Centers

★ ★ ★ ★ ☆

SAGE neurologists diagnose and treat diseases of the brain, spinal cord, nerves, and muscles. Commonly treated diseases include epilepsy, intervertebral disc disease (i.e., a slipped disc), meningitis, and neuromuscular diseases, as well as tumors of the brain and spine.

Neurology in the Bay Area, CA | SAGE Veterinary Centers

SAGE Nursing News | SAGE Publications Inc

★ ★ ★ ★ ☆

Now published by SAGE! Epilepsy Currents is an open access, bi-monthly current-awareness journal providing reviews, commentaries and abstracts from the world’s literature on the research and treatment of epilepsy. The journal is highly ranked, with an Impact Factor of 9.333 and is published in affiliation with the American Epilepsy Society (AES).

SAGE Nursing News | SAGE Publications Inc

NATURAL SAGE - White Sage Information

★ ★ ★ ★ ☆

White Sage Information Page describes the Organic Chemicals in White Sage Essential Oils and the Past and Present Uses of the the White Sage Plant itself, since we grow our own White Sage and Distill our own Essential Oils, plus use both plant and oils in our products.

NATURAL SAGE - White Sage Information

SAGE Reference - Epilepsy - sk.sagepub.com

★ ★ ★ ★ ☆

SAGE Video Bringing teaching, learning and research to life. SAGE Books The ultimate social sciences digital library. SAGE Reference The complete guide for your research journey. SAGE Navigator The essential social sciences literature review tool. SAGE Business Cases Real world cases at your fingertips. CQ Press Your definitive resource for politics, policy and people.

SAGE Reference - Epilepsy - sk.sagepub.com
Devil-musician-bible-study.html,Diaconia-journal-for-the-study.html,Dilalla-study-guide.html,Disadvantages-study-in-australia.html,Disciple-bible-study-atlanta.html